ProCE Banner Activity

COVID-19: Omicron Transmissibility, Severity, and Vaccine Effectiveness

Podcast Episodes
Transmissibility, disease severity, and vaccine effectiveness are different with the SARS-CoV-2 omicron variant compared with the ancestral virus and prior variants. Hear expert faculty discuss what we know about omicron.

Released: February 22, 2022

Expiration: February 21, 2023

Share

Faculty

Sharon R. Lewin

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Melbourne Laureate Professor and Head, Department of Infectious Disease, The University of Melbourne
Consultant Physician, Royal Melbourne and Alfred Hospitals
Melbourne, Australia

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Melbourne Laureate Professor and Head, Department of Infectious Disease, The University of Melbourne
Consultant Physician, Royal Melbourne and Alfred Hospitals
Melbourne, Australia

Sharon R. Lewin, AO, FRACP, PhD, FAAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.